Frye, Mark A <br/><br/>
Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development.  [electronic resource] 

 -  Journal of clinical psychopharmacology  Jun 2015 
 - 334-6 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-712X 
<br/><br/><label>Standard No.: </label>10.1097/JCP.0000000000000316  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antidepressive Agents--therapeutic use<br/>Benzodiazepines--pharmacology<br/>Clinical Trials as Topic--methods<br/>Depression--drug therapy<br/>Depressive Disorder, Treatment-Resistant--drug therapy<br/>Humans<br/>Ketamine--antagonists & inhibitors